These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15901925)

  • 1. Sulforhodamine B assay and chemosensitivity.
    Voigt W
    Methods Mol Med; 2005; 110():39-48. PubMed ID: 15901925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New colorimetric cytotoxicity assay for anticancer-drug screening.
    Skehan P; Storeng R; Scudiero D; Monks A; McMahon J; Vistica D; Warren JT; Bokesch H; Kenney S; Boyd MR
    J Natl Cancer Inst; 1990 Jul; 82(13):1107-12. PubMed ID: 2359136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cell proliferation and cell death based assays in chemosensitivity testing.
    Gerçel-Taylor C; Ackermann MA; Taylor DD
    Anticancer Res; 2001; 21(4A):2761-8. PubMed ID: 11724352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro assays of chemotherapeutic sensitivity.
    Carney DN; Winkler CF
    Important Adv Oncol; 1985; ():78-103. PubMed ID: 3916747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
    Haselsberger K; Peterson DC; Thomas DG; Darling JL
    Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents.
    Mirzayans R; Andrais B; Scott A; Tessier A; Murray D
    J Pharm Pharm Sci; 2007; 10(2):298s-311s. PubMed ID: 17718933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity.
    Houghton P; Fang R; Techatanawat I; Steventon G; Hylands PJ; Lee CC
    Methods; 2007 Aug; 42(4):377-87. PubMed ID: 17560325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines.
    Perez RP; Godwin AK; Handel LM; Hamilton TC
    Eur J Cancer; 1993; 29A(3):395-9. PubMed ID: 8398340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorimetric chemosensitivity testing using sulforhodamine B.
    Kubota T; Takahara T; Nagata M; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M
    J Surg Oncol; 1993 Feb; 52(2):83-8. PubMed ID: 8468977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.
    Keepers YP; Pizao PE; Peters GJ; van Ark-Otte J; Winograd B; Pinedo HM
    Eur J Cancer; 1991; 27(7):897-900. PubMed ID: 1834124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ChemoFx assay: an ex vivo cell culture assay for predicting anticancer drug responses.
    Ochs RL; Burholt D; Kornblith P
    Methods Mol Med; 2005; 110():155-72. PubMed ID: 15901934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
    Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents.
    Fricker SP; Buckley RG
    Anticancer Res; 1996; 16(6B):3755-60. PubMed ID: 9042253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key considerations when using the sulforhodamine B assay for screening novel anticancer agents.
    Shakil MS; Rana Z; Hanif M; Rosengren RJ
    Anticancer Drugs; 2022 Jan; 33(1):6-10. PubMed ID: 34261912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of chemosensitivity testing.
    Blumenthal RD
    Methods Mol Med; 2005; 110():3-18. PubMed ID: 15901922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrophotometric determination of clonogenic capacity of leukemic cells in a semisolid microtiter culture system.
    Schweitzer CM; van de Loosdrecht AA; Jonkhoff AR; Ossenkoppele GJ; Huijgens PC; Dräger AM; Broekhoven MG; Langenhuijsen MM
    Exp Hematol; 1993 Apr; 21(4):573-8. PubMed ID: 8462666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
    Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR
    J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescently labeled liposomes for monitoring cholera toxin binding to epithelial cells.
    Edwards KA; Duan F; Baeumner AJ; March JC
    Anal Biochem; 2008 Sep; 380(1):59-67. PubMed ID: 18549803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines.
    Fernando A; Glaysher S; Conroy M; Pekalski M; Smith J; Knight LA; Di Nicolantonio F; Cree IA
    Anticancer Drugs; 2006 Sep; 17(8):913-9. PubMed ID: 16940801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.